Learn More
Medchemexpress LLC Rho-Kinase-IN-2 | 2573071-18-6 | C20H25FN4O2 | 5 MG

Supplier: Medchemexpress LLC HY1506405MG
Rho-Kinase-IN-2 (Compound 23) is an orally active, selective, and CNS-penetrant Rho Kinase (ROCK) inhibitor with a ROCK2 IC50 of 3 nM. This compound is suitable for use in Huntington's research, demonstrating concentration-dependent effects in vitro and dose- and time-dependent target engagement in vivo.
- Orally active, selective, and CNS-penetrant Rho Kinase (ROCK) inhibitor
- ROCK2 IC50 of 3 nM
- Suitable for Huntington's research applications
- Increases AKT phosphorylation and decreases MYPT1 phosphorylation in cell studies
- Shows dose- and time-dependent ROCK1 and ROCK2 target engagement in animal models
- Exhibits excellent tolerability in mice models
- Provides a direct dose- and time-dependent relationship between brain exposure and MYPT1 phosphorylation status
- Decreases mean arterial, systolic, and diastolic blood pressure, and heart rate in CD1 mice
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.